Abstract
In this study, we aimed to identify the current trend of novel psychoactive substance (NPS) consumption in Italy and the level of knowledge about NPS in the general population and to explore the presence of risk factors for a lifetime NPS misuse. We conducted an anonymous online survey, administered to a large sample of people of any age living in Italy, asking for their knowledge about NPS as well as their history of drug use. Descriptive statistics were reported, and regression analyses were performed to identify risk factors for lifetime use of NPS. A total of 1097 individuals gave a valid response to the survey. A lifetime use of NPS was reported by 13.5%. Multivariate regression analysis showed that male gender (OR 2.33, 95% CI 1.52–3.55), homosexual sexual orientation (OR 2.52, 95% CI 1.21–5.27), a use of emergency services due to alcohol (OR 3.38, 95% CI 2.23–5.12) and previous contact with mental health services (OR 1.58, 95% CI 1.04–2.41) were risk factors for a lifetime use of NPS (p < 0.05). An improvement of preventive strategies and simplified access to information on NPS, especially tailored to individuals at increased risk of misuse, could slow diffusion of NPS and avert the consequences of substance use.
Similar content being viewed by others
Data Availability
The full questionnaire and the Appendix are available as supplementary material freely accessible at https://github.com/carolzangani/SurveyNPS.git.
References
Abdulrahim, D., & Bowden-Jones, O. (2015). Guidance on the management of acute and chronic harms of club drugs and novel psychoactive substances. Novel Psychoactive Treatment UK Network (NEPTUNE).
Andrade, A. G., Duarte, P., Barroso, L. P., Nishimura, R., Alberghini, D. G., & Oliveira, L. G. (2012). Use of alcohol and other drugs among Brazilian college students: Effects of gender and age. Revista brasileira de psiquiatria (Sao Paulo, Brazil: 1999), 34(3), 294–305.
Anzillotti, L., Calò, L., Banchini, A., Schirripa, M. L., Marezza, F., & Cecchi, R. (2020). Mephedrone and chemsex: A case report. Legal Medicine, 42, 101640. https://doi.org/10.1016/j.legalmed.2019.101640
Assi, S., Gulyamova, N., Ibrahim, K., Kneler, P., & Osselton, D. (2017). Profile, effects, and toxicity of novel psychoactive substances: A systematic review of quantitative studies. Human Psychopharmacology: Clinical and Experimental, 32, e2607. https://doi.org/10.1002/hup2607
Benschop, A., Urbán, R., Kapitány-Fövény, M., et al. (2020). Why do people use new psychoactive substances? Development of a new measurement tool in six European countries. Journal of Psychopharmacology, 34(6), 600–611. https://doi.org/10.1177/0269881120904951
Bourne, A., Reid, D., Hickson, F., Torres-Rueda, S., & Weatherburn, P. (2015). Illicit drug use in sexual settings (‘chemsex’) and HIV/STI transmission risk behaviour among gay men in South London: Findings from a qualitative study. Sexually Transmitted Infections, 91(8), 564–568.
Bourne, A., Ong, J., & Pakianathan, M. (2018). Sharing solutions for a reasoned and evidence-based response: Chemsex/party and play among gay and bisexual men. Sex Health, 15(2), 99. https://doi.org/10.1071/SH18023
Chiappini, S., Mosca, A., Miuli, A., Santovito, M. C., Orsolini, L., Corkery, J. M., Guirguis, A., Pettorruso, M., Martinotti, G., Di Giannantonio, M., & Schifano, F. (2021). New psychoactive substances and suicidality: A systematic review of the current literature. Medicina (kaunas, Lithuania), 57(6), 580. https://doi.org/10.3390/medicina57060580
Debnam, K. J., Saha, S., & Bradshaw, C. P. (2018). Synthetic and other drug use among high school students: The role of perceived prevalence, access, and harms. Substance Use and Misuse, 53(12), 2069–2076. https://doi.org/10.1080/10826084.2018.1455699
Deligianni, E., Corkery, J. M., Schifano, F., & Lione, L. A. (2017). An international survey on the awareness, use, preference, and health perception of novel psychoactive substances (NPS). Human Psychopharmacology: Clinical and Experimental, 32(3), e2581. https://doi.org/10.1002/hup.2581
ESPAD. (2015). ESPAD report 2015. doi: https://doi.org/10.2810/86718.
Eurobarometer. (2011). Youth attitudes on drugs. Analytical report. European Commission, 1–20.
European Monitoring Centre for Drug and Drug Addiction. (2019). European Drug Report 2019: Trends and Developments. http://www.emcdda.europa.eu/publications/edr/trends-developments/2019. Accessed 31 Oct 2021.
European Monitoring Centre for Drugs and Drug Addiction. (2017). Drugs and the darknet. https://doi.org/10.2810/783427
European Monitoring Centre for Drugs and Drug Addiction. (2002). Handbook for surveys on drug use among the general population. (EMCDDA project CT.99.EP.08 B). EMCDDA Proj CT99EP08B. http://www.emcdda.europa.eu/html.cfm/index58052EN.html_en. Accessed 31 Oct 2021.
Griffin, K. W., Lowe, S. R., Botvin, C., & Acevedo, B. P. (2019). Patterns of adolescent tobacco and alcohol use as predictors of illicit and prescription drug abuse in minority young adults. Journal of Prevention & Intervention in the Community, 47(3), 228–242. https://doi.org/10.1080/10852352.2019.1603672
Guirguis, A. (2017). New psychoactive substances: A public health issue. The International Journal of Pharmacy Practice, 25(5), 323–325. https://doi.org/10.1111/ijpp.12313
Kelly, B. C., Wells, B. E., Pawson, M., Leclair, A., Parsons, J. T., & Golub, S. A. (2013). Novel psychoactive drug use among younger adults involved in US nightlife scenes. Drug and Alcohol Review, 32(6), 588–593. https://doi.org/10.1111/dar.12058
Lane, P. W., & Nelder, J. A. (1982). Analysis of covariance and standardization as instances of prediction. Biometrics, 38(3), 613–621.
Lawn, W., Aldridge, A., Xia, R., & Winstock, A. R. (2019). Substance-linked sex in heterosexual, homosexual, and bisexual men and women: An online, cross-sectional “Global Drug Survey” report. The Journal of Sexual Medicine, 16(5), 721–732. https://doi.org/10.1016/j.jsxm.2019.02.018
Lea, T., Prestage, G., Mao, L., Zablotska, I., de Wit, J., & Holt, M. (2013). Trends in drug use among gay and bisexual men in Sydney, Melbourne and Queensland, Australia. Drug and Alcohol Review, 32(1), 39–46. https://doi.org/10.1111/j.1465-3362.2012.00494.x
Loeffler, G., Delaney, E., & Hann, M. (2016). International trends in spice use: Prevalence, motivation for use, relationship to other substances, and perception of use and safety for synthetic cannabinoids. Brain Research Bulletin, 126, 8–28. https://doi.org/10.1016/j.brainresbull.2016.04.013
Logan, B. K., Mohr, A. L. A., Friscia, M., Krotulski, A. J., Papsun, D. M., Kacinko, S. L., Ropero-Miller, J. D., & Huestis, M. A. (2017). Reports of adverse events associated with use of novel psychoactive substances, 2013–2016: A review. Journal of Analytical Toxicology, 41, 573–610. https://doi.org/10.1093/jat/bkx03
Long, J. S, Freese, J. (2014). Regression models for categorical dependent variables using STATA (1st ed.). STATA Corporation, 4905 Lakeway Drive, College Station, Texas, 77845: Stata Press.
Mader, J., Smith, J. M., Smith, J., & Christensen, D. R. (2020). Protocol for a feasibility study investigating the UCalgary’s Cannabis Café: Education and harm reduction initiative for postsecondary students. British Medical Journal Open, 10(2), e032651. https://doi.org/10.1136/bmjopen-2019-032651
Martinotti, G., Lupi, M., Carlucci, L., et al. (2015). Novel psychoactive substances: Use and knowledge among adolescents and young adults in urban and rural areas. Human Psychopharmacology: Clinical and Experimental, 30(4), 295–301. https://doi.org/10.1002/hup.2486
Maxwell, S., Shahmanesh, M., & Gafos, M. (2019). Chemsex behaviours among men who have sex with men: A systematic review of the literature. The International Journal on Drug Policy, 63, 74–89. https://doi.org/10.1016/j.drugpo.2018.11.014
Mbanga, C. M., Efie, D. T., Aroke, D., & Njim, T. (2018). Prevalence and predictors of recreational drug use among medical and nursing students in Cameroon: A cross sectional analysis. BMC Research Notes, 11(1), 515. https://doi.org/10.1186/s13104-018-3631-z
Mereish, E. H. (2019). Substance use and misuse among sexual and gender minority youth. Current Opinion in Psychology, 30, 123–127. https://doi.org/10.1016/j.copsyc.2019.05.002
Midgley, L. S., Murphy, S., Moore, G., Hewitt, G., & White, J. (2018). Multilevel population-based cross-sectional study examining school substance-misuse policy and the use of cannabis, mephedrone and novel psychoactive substances among students aged 11–16 years in schools in Wales. British Medical Journal Open, 8(6), e020737. https://doi.org/10.1136/bmjopen-2017-020737
Neicun, J., Yang, J. C., Shih, H., et al. (2020). Lifetime prevalence of novel psychoactive substances use among adults in the USA: Sociodemographic, mental health and illicit drug use correlates. Evidence from a population-based survey 2007–2014. PLoS One, 15(10), e0241056. https://doi.org/10.1371/journal.pone.0241056
Orsolini, L., Chiappini, S., Corkery, J. M., Guirguis, A., Papanti, D., & Schifano, F. (2019). The use of new psychoactive substances (NPS) in young people and their role in mental health care: A systematic review. Expert Review of Neurotherapeutics, 19(12), 1253–1264. https://doi.org/10.1080/14737175.2019.1666712
Orsolini, L., Papanti, G. D., Francesconi, G., & Schifano, F. (2015). Mind navigators of chemicals’ experimenters? A Web-based description of e-psychonauts. Cyberpsychology, Behavior and Social Networking, 18(5), 296–300. https://doi.org/10.1089/cyber.2014.0486
Orsolini, L., St John-Smith, P., McQueen, D., Papanti, D., Corkery, J., & Schifano, F. (2017). Evolutionary considerations on the emerging subculture of the e-psychonauts and the novel psychoactive substances: A comeback to the shamanism? Current Neuropharmacology, 15(5), 731–737. https://doi.org/10.2174/1570159X15666161111114838
Ostuzzi, G., Mazzi, M. A., Terlizzi, S., et al. (2018). Factors associated with first- versus second-generation long-acting antipsychotics prescribed under ordinary clinical practice in Italy. Mazza M, ed. PLoS One, 13(8), e0201371. https://doi.org/10.1371/journal.pone.0201371
Palamar, J. J., Martins, S. S., Su, M. K., & Ompad, D. C. (2015). Self-reported use of novel psychoactive substances in a US nationally representative survey: Prevalence, correlates, and a call for new survey methods to prevent underreporting. Drug and Alcohol Dependence, 156, 112–119. https://doi.org/10.1016/j.drugalcdep.2015.08.028
Palamar, J. J., Su, M. K., & Hoffman, R. S. (2016). Characteristics of novel psychoactive substance exposures reported to New York City Poison Center, 2011–2014. American Journal of Drug and Alcohol Abuse, 42(1), 39–47. https://doi.org/10.3109/00952990.2015.1106551
Patrick, M. E., O’Malley, P. M., Kloska, D. D., et al. (2016). Novel psychoactive substance use by US adolescents: Characteristics associated with use of synthetic cannabinoids and synthetic cathinones. Drug and Alcohol Review, 35(5), 586–590. https://doi.org/10.1111/dar.12372
Penney, J., Dargan, P. I., Padmore, J., Wood, D. M., & Norman, I. J. (2016). Epidemiology of adolescent substance use in London schools. QJM, 109(6), 405–409. https://doi.org/10.1093/qjmed/hcv171
Pérez, A., Osman, A., Peña, L., et al. (2018). Parent education and substance use among Latin American early adolescents. Health Behavior and Policy Review, 5(3), 91–99. https://doi.org/10.14485/HBPR.5.3.9
R Core Team. (2017). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. https://www.R-project.org/. Accessed 31 Oct 2021.
Rajan, S., Ruggles, K. V., Guarino, H., & Mateu-Gelabert, P. (2018). Heroin use and drug injection among youth also misusing prescription drugs. American Journal of Health Behavior, 42(1), 144–155. https://doi.org/10.5993/AJHB.42.1.14
Roderick, E., Penney, J., Murrells, T., Dargan, P. I., & Norman, I. J. (2018). Epidemiology of adolescent substance use in Norfolk schools. QJM: An International Journal of Medicine, 111(10), 699–706. https://doi.org/10.1093/qjmed/hcy153
Santa Maria, D., Padhye, N., Yang, Y., Gallardo, K., Santos, G. M., Jung, J., & Businelle, M. (2018). Drug use patterns and predictors among homeless youth: Results of an ecological momentary assessment. American Journal of Drug and Alcohol Abuse, 44(5), 551–560. https://doi.org/10.1080/00952990.2017.1407328
Schepis, T. S., Teter, C. J., & McCabe, S. E. (2018). Prescription drug use, misuse and related substance use disorder symptoms vary by educational status and attainment in U.S. adolescents and young adults. Drug and Alcohol Dependence, 189, 172–177. https://doi.org/10.1016/j.drugalcdep.2018.05.017
Schifano, F. (2015). Novel psychoactive substances (NPS): Clinical and pharmacological issues. Drugs and Alcohol Today, 15(1), 21–27. https://doi.org/10.1108/DAT-10-2014-0035
Schifano, F., Albanese, A., Fergus, S., et al. (2011). Mephedrone (4-methylmethcathinone; ‘meow meow’): Chemical, pharmacological and clinical issues. Psychopharmacology (Berl), 214(3), 593–602. https://doi.org/10.1007/s00213-010-2070-x
Schifano, F., Chiappini, S., Corkery, J. M., Scherbaum, N., & Guirguis, A. (2021a). The e-psychonaut drugs’ psychopharmacology. Current Opinion in Pharmacology, 57, 165–174. https://doi.org/10.1016/j.coph.2021.02.008
Schifano, F., Napoletano, F., Chiappini, S., Guirguis, A., Corkery, J. M., Bonaccorso, S., Ricciardi, A., Scherbaum, N., & Vento, A. (2021b). New/emerging psychoactive substances and associated psychopathological consequences. Psychological Medicine, 51(1), 30–42. https://doi.org/10.1017/S0033291719001727
Schifano, F., Orsolini, L., Papanti, G. D., & Corkery, J. M. (2015). Novel psychoactive substances of interest for psychiatry. World Psychiatry, 14(1), 15–26. https://doi.org/10.1002/wps.20174
Schilling, L., Zeeb, H., Pischke, C., et al. (2017). Licit and illicit substance use patterns among university students in Germany using cluster analysis. Substance Abuse Treatment, Prevention, and Policy, 12(1), 44. https://doi.org/10.1186/s13011-017-0128-z
Simonato, P., Corazza, O., Santonastaso, P., et al. (2013). Novel psychoactive substances as a novel challenge for health professionals: Results from an Italian survey. Human Psychopharmacology: Clinical and Experimental, 28(4), 324–331. https://doi.org/10.1002/hup.2300
SondaggioOnline. (2019). www.sondaggio-online.com. Accessed 31 Oct 2021.
Soussan, C., Andersson, M., & Kjellgren, A. (2018). The diverse reasons for using novel psychoactive substances - A qualitative study of the users’ own perspectives. The International Journal on Drug Policy, 52, 71–78. https://doi.org/10.1016/j.drugpo.2017.11.003
Soussan, C., & Kjellgren, A. (2014). Harm reduction and knowledge exchange-A qualitative analysis of drug-related Internet discussion forums. Harm Reduction Journal, 11, 25. https://doi.org/10.1186/1477-7517-11-25
Soussan, C., & Kjellgren, A. (2016). The users of novel psychoactive substances: Online survey about their characteristics, attitudes and motivations. The International Journal on Drug Policy, 32, 77–84. https://doi.org/10.1016/j.drugpo.2016.03.007
StataCorp. Stata statistical software: Release 14. 2015.
UNODC. (2013). The challenge of new psychoactive substances. A report from the Global SMART Programme March 2013. https://www.unodc.org/documents/scientific/NPS_Report.pdf. Accessed 31 Oct 2021.
UNODC. (2014). Global synthetic drugs assessment 2014. https://www.unodc.org/documents/scientific/2014_Global_Synthetic_Drugs_Assessment_web.pdf. Accessed 31 Oct 2021.
UNODC. (2020). What are NPS? https://www.unodc.org/LSS/Page/NPS. Accessed 31 Oct 2021.
Vaccher, S. J., Hammoud, M. A., Bourne, A., et al. (2020). Prevalence, frequency, and motivations for alkyl nitrite use among gay, bisexual and other men who have sex with men in Australia. The International Journal on Drug Policy, 76, 102659. https://doi.org/10.1016/j.drugpo.2019.102659
Vento, A. E., Martinotti, G., Cinosi, E., et al. (2014). Substance use in the club scene of Rome: A pilot study. BioMed Research International, 1–5. https://doi.org/10.1155/2014/617546
Wood, D. M., Hunter, L., Measham, F., & Dargan, P. I. (2012). Limited use of novel psychoactive substances in South London nightclubs. QJM, 105(10), 959–964. https://doi.org/10.1093/qjmed/hcs107
Zhao, P., Tang, S., Wang, C., et al. (2017). Recreational drug use among Chinese MSM and transgender individuals: Results from a national online cross-sectional study. Meng, Z ed. PLoS One, 12(1), e0170024. https://doi.org/10.1371/journal.pone.0170024
Acknowledgements
The authors thank ASST Santi Paolo e Carlo di Milano for the patronage, and Progetto Itaca, SIP Lombardia and SIAPAD for their support. The views expressed are those of the authors and not necessarily those of the UK National Health Service, the NIHR or the Department of Health and Social Care.
Author information
Authors and Affiliations
Contributions
Caroline Zangani conceptualised the research. Protocol and material preparation was performed by Armando D’Agostino, Barbara Giordano, Caroline Zangani and Edoardo Giuseppe Ostinelli. All the authors contributed to the diffusion of the survey. Caroline Zangani and Edoardo Giuseppe Ostinelli performed the statistical analyses and drafted the manuscript. All the authors contributed to finalise the paper and agreed to the final version.
Corresponding author
Ethics declarations
Ethics Approval
All the study procedures described were approved by the University of Milan Ethics Committee before its starting date.
Conflict of Interest
Fabrizio Schifano was a member of the UK Advisory Council on the Misuse of Drugs (ACMD; 2011-2019) and is currently a member of the EMA Advisory Board (Psychiatry). Edoardo G. Ostinelli has received research and consultancy fees from Angelini Pharma and he is funded by the National Institute for Health Research (NIHR) Research Professorship to Professor Andrea Cipriani (grant RP-2017–08-ST2-006) and by the NIHR Applied Research Collaboration Oxford and Thames Valley (ARC OxTV) at Oxford Health NHS Foundation Trust. Caroline Zangani is supported by the National Institute for Health Research (NIHR) Oxford cognitive health Clinical Research Facility and by the NIHR Oxford Health Biomedical Research Centre (grant BRC-1215–20005). All other authors declare no conflict of interests. The supporters had no role in the design, analysis, interpretation or publication of this study. The views expressed are those of the authors and not necessarily those of the UK National Health Service, the NIHR, or the Department of Health and Social Care.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Zangani, C., Ostinelli, E.G., Giordano, B. et al. Knowledge and Use of Novel Psychoactive Substances in Italy: a Survey-Based Study in the General Population. Int J Ment Health Addiction 21, 1679–1699 (2023). https://doi.org/10.1007/s11469-021-00683-z
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11469-021-00683-z